Switzerland-based Actelion ( ALIOF ) recently submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for the approval of its pulmonary arterial hypertension
Switzerland-based Actelion ( ALIOF ) recently submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for the approval of its pulmonary arterial hypertension